Given the close association of PSC with IBD, the occurrence of aGP2 IgA in severe PSC (7) provided further evidence for the correlation of the mucosal loss of tolerance to GP2 with fibrostenotic changes as reported in IBD (22). The gene discussed is CD79A; the disease is pancreatic serous cystadenoma.